ARNI — Arno Therapeutics Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Arno Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.91 | -14.4 | -39.7 | 7.77 | -11.5 |
| Depreciation | |||||
| Non-Cash Items | 1.1 | 4.18 | 24.6 | -24.7 | 1.55 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.039 | 0.777 | 0.781 | -1.92 | -0.02 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -6.83 | -9.42 | -14.2 | -18.8 | -9.97 |
| Capital Expenditures | -0.023 | 0 | 0 | -0.02 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0 | 0 | -0 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.023 | 0 | 0 | -0.02 | 0 |
| Financing Cash Flow Items | 0 | -1.17 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.006 | 13.7 | 30.1 | 0 | 2.08 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.85 | 4.27 | 15.8 | -18.8 | -7.88 |